/Investor DB

Advantage Capital Partners — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

MedRhythmsmedrhythms.comin𝕏Jul 2021

MedRhythms develops digital therapeutics using music, sensors, and software combined with neuroscience to improve walking and mobility in patients with neurological conditions including stroke, multiple sclerosis, and Parkinson's disease.

AI & Machine LearningDigital HealthMedical DevicesBoston, US

Brian Harris(Co-Founder and CEO)inOwen McCarthy(Executive Officer, Director)inRaymond Pawlicki(Director)Musan Duric(Director)

BoardWilliam McKee(Director)Isaac Cheng(Director)

Co-investorsBose VenturesCEI VenturesGlobal BrainPeterson VenturesMaine Venture Fund

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Shenandoah Growers

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.